Surveillance Versus Bronchoscopy After Airway Stenting

Last updated: April 11, 2025
Sponsor: Icahn School of Medicine at Mount Sinai
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

Bronchoscopy

Clinical Study ID

NCT06935695
STUDY-24-01352
  • Ages > 18
  • All Genders

Study Summary

Randomized, pilot study that evaluates surveillance bronchoscopy versus no surveillance for patients that undergo tracheobronchial stenting

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • All adult patients that undergo central airway (trachea, main stem bronchi andbronchus intermedius) stenting.

Exclusion

Exclusion Criteria:

  • Inability to obtain informed consent due to cognitive, neurologic or psychiatricimpairment.

  • Lobar or segmental stents alone

  • Terminally ill patients considered too sick to undergo a follow-up surveillancebronchoscopy

  • Stent insertion as a trial for excessive central airway collapse (as the duration ofthese stents is only 1-2 weeks)

  • Patients with a tracheostomy (as these patients can undergo frequent in-linesuctioning that can affect the outcomes being assessed)

Study Design

Total Participants: 50
Treatment Group(s): 1
Primary Treatment: Bronchoscopy
Phase:
Study Start date:
January 01, 2025
Estimated Completion Date:
March 31, 2026

Connect with a study center

  • The Mount Sinai Health System

    New York, New York 10029
    United States

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.